Stem Cell Engraftment
Cardiac function improved via engraftment of enriched embryonic stem cells and other medication
Published in Heart Disease Weekly, March 26th, 2006
According to researchers working in the United States, "A major limitation of stem cell transfer is early donor-cell death. [In our report], we seek to enhance myocardial repair following injury through transplantation of cardiomyocyte-enriched human embryonic stem cells (hESC) and recipient treatment with cytoprotective (allopurinol + uricase) and anti-inflammatory (ibuprofen) agents."
"We injected 106 (15% hESC-derived cardiomyocytes) green fluorescent protein (GFP+) hESC in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
Source: Heart Disease Weekly (2006-03-26)
More Articles from Heart Disease Weekly
- Angiology
Endothelium-independent vasorelaxation is induced by protamine sulfate via NO synthase pathway - Ischemia
In ischemia, enhanced NO may balance ATP supply/demand and protect cells from reperfusion injury - Myocardial Infarction
In acute myocardial infarction treated with PCI, left ventricular diastolic function predicts outcome - Adverse Drug Reaction
Public health advisory for Trasylol issued by U.S. FDA - Angina
Update on GENASIS trial announced by Corautus Genetics - Angiology
Carotid artery contractility decreased after acute pressure overload in rat model - More from this issue of Heart Disease Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
